These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32833192)

  • 1. Client-Centered Adherence Counseling with Adherence Measurement Feedback to Support Use of the Dapivirine Ring in MTN-025 (The HOPE Study).
    Balán IC; Giguere R; Lentz C; Kutner BA; Kajura-Manyindo C; Byogero R; Asiimwe FB; Makala Y; Jambaya J; Khanyile N; Chetty D; Soto-Torres L; Mayo A; Mgodi NM; Palanee-Phillips T; Baeten JM
    AIDS Behav; 2021 Feb; 25(2):447-458. PubMed ID: 32833192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women's experience receiving drug feedback and adherence counseling in MTN-025/HOPE - an HIV Prevention open-label trial of the Dapivirine Vaginal Ring.
    Katz AWK; Balán IC; Reddy K; Etima J; Weber K; Tauya T; Atujuna M; Scheckter R; Ngure K; Soto-Torres L; Mgodi N; Palanee-Phillips T; Baeten JM; van der Straten A
    AIDS Behav; 2022 Nov; 26(11):3607-3619. PubMed ID: 35536519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Counselors' acceptability of adherence counseling session recording, fidelity monitoring, and feedback in a multi-site HIV prevention study in four African countries.
    Giguere R; Lentz C; Kajura-Manyindo C; Kutner BA; Dolezal C; Buthelezi M; Lukas I; Nampiira S; Rushwaya C; Sitima E; Katz A; van der Straten A; Balán IC
    AIDS Care; 2020; 32(sup1):19-28. PubMed ID: 33021118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of a Relationship-focused Counseling Intervention with Delivery of the Dapivirine Ring for HIV Prevention to Women in Johannesburg: Results of the CHARISMA Pilot Study.
    Montgomery ET; Roberts ST; Reddy K; Tolley E; Hartmann M; Wilson E; Mathebula F; Wagner LD; Zissette S; Lanham M; Wilcher R; Baeten JM; Palanee-Phillips T
    AIDS Behav; 2022 Mar; 26(3):752-763. PubMed ID: 34546473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative Perceptions of Dapivirine VR Adherence and Drug Level Feedback Following an Open-Label Extension Trial.
    Naidoo K; Mansoor LE; Katz AWK; Garcia M; Kemigisha D; Morar NS; Zimba CC; Chitukuta M; Reddy K; Soto-Torres L; Naidoo S; Montgomery ET
    J Acquir Immune Defic Syndr; 2021 Apr; 86(4):e90-e96. PubMed ID: 33278181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Power of the Shared Experience: MTN-020/ASPIRE Trial Participants' Descriptions of Peer Influence on Acceptability of and Adherence to the Dapivirine Vaginal Ring for HIV Prevention.
    Katz AWK; Naidoo K; Reddy K; Chitukuta M; Nabukeera J; Siva S; Zimba C; Montgomery ET
    AIDS Behav; 2020 Aug; 24(8):2387-2399. PubMed ID: 31980993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Culturally-Based Challenges to and Recommendations for Delivering Adherence Counseling in a Multicultural Biomedical HIV Prevention Trial in Four African Countries.
    Lentz C; Giguere R; Kutner BA; Dolezal C; Kajura-Manyindo C; Yambira M; Asiimwe F; Mugocha C; Mwenda W; Ndlovu T; Naidu N; Madlala B; Balán IC
    AIDS Educ Prev; 2020 Dec; 32(6):512-527. PubMed ID: 33779210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of a fidelity monitoring process to assess delivery of an evidence-based adherence counseling intervention in a multi-site biomedical HIV prevention study.
    Balán IC; Lentz C; Giguere R; Mayo AJ; Rael CT; Soto-Torres L; Palanee-Phillips T; Mgodi NM; Hillier S; Baeten JM;
    AIDS Care; 2020 Sep; 32(9):1082-1091. PubMed ID: 31899954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence.
    Stoner MCD; Brown ER; Palanee-Phillips T; Mansoor LE; Tembo T; Nair G; Akello C; Seyama L; Jeenarain N; Naidoo L; Mgodi N; Hunidzarira P; Chitukuta M; van der Straten A;
    AIDS Behav; 2021 Dec; 25(12):4169-4179. PubMed ID: 33939034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study.
    Baeten JM; Palanee-Phillips T; Mgodi NM; Mayo AJ; Szydlo DW; Ramjee G; Gati Mirembe B; Mhlanga F; Hunidzarira P; Mansoor LE; Siva S; Govender V; Makanani B; Naidoo L; Singh N; Nair G; Chinula L; Parikh UM; Mellors JW; Balán IC; Ngure K; van der Straten A; Scheckter R; Garcia M; Peda M; Patterson K; Livant E; Bunge K; Singh D; Jacobson C; Jiao Y; Hendrix CW; Chirenje ZM; Nakabiito C; Taha TE; Jones J; Torjesen K; Nel A; Rosenberg Z; Soto-Torres LE; Hillier SL; Brown ER;
    Lancet HIV; 2021 Feb; 8(2):e87-e95. PubMed ID: 33539762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sharing Objective Measures of Adherence to a Vaginal Microbicide Promotes Candor About Actual Use and Bolsters Motivation to Prevent HIV.
    Kutner BA; Giguere R; Lentz C; Kajura-Manyindo C; Dolezal C; Butheliezi S; Gwande M; Nampiira S; Ndlovu T; Mvinjelwa P; Mwenda W; Balán IC
    AIDS Behav; 2021 Mar; 25(3):721-731. PubMed ID: 32920652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa.
    Nel A; Bekker LG; Bukusi E; Hellstrӧm E; Kotze P; Louw C; Martinson F; Masenga G; Montgomery E; Ndaba N; van der Straten A; van Niekerk N; Woodsong C
    PLoS One; 2016; 11(3):e0147743. PubMed ID: 26963505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/ASPIRE study.
    Garcia M; Luecke E; Mayo AJ; Scheckter R; Ndase P; Kiweewa FM; Kemigisha D; Musara P; Mansoor LE; Singh N; Woeber K; Morar NS; Jeenarain N; Gaffoor Z; Gondwe DK; Makala Y; Fleurs L; Reddy K; Palanee-Phillips T; Baeten JM; van der Straten A; Soto-Torres L; Torjesen K
    BMC Public Health; 2021 Nov; 21(1):2041. PubMed ID: 34749675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inconsistent Counselor Fidelity in Delivering an Evidence-Based Adherence Intervention During a PrEP Trial.
    Balán IC; Lentz C; Giguere R; Dolezal C; Kajura-Manyindo C; Kutner BA; Zalwango A; Makoni R; Madlala B; Makala Y; Khanyile N; Kadyamusuma M; Kachenjera L; Ndhlovu-Forde Z; Tuswa-Haynes N
    AIDS Behav; 2022 Mar; 26(3):698-708. PubMed ID: 34390433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the Ring Work? Perceptions and Understanding of the Efficacy of a Dapivirine Vaginal Ring for HIV Prevention Amongst Women in a Placebo-Controlled Trial.
    Etima J; Katz AWK; Duby Z; Garcia M; Palanee-Phillips T; Reddy K; Mathebula F; Zimba C; Mansoor LE; Singh D; Manengamambo E; Naidoo S; Soto-Torres L; Montgomery ET;
    AIDS Behav; 2022 May; 26(5):1597-1606. PubMed ID: 34727272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes and perceptions towards novel objective measures of ARV-based vaginal ring use: Results from a global stakeholder survey.
    Stalter RM; Tharaldson J; Owen DH; Okumu E; Moench T; Mack N; Tolley EE; MacQueen KM
    PLoS One; 2017; 12(7):e0180963. PubMed ID: 28708847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial.
    Mayo AJ; Browne EN; Montgomery ET; Torjesen K; Palanee-Phillips T; Jeenarain N; Seyama L; Woeber K; Harkoo I; Reddy K; Tembo T; Mutero P; Tauya T; Chitukuta M; Gati Mirembe B; Soto-Torres L; Brown ER; Baeten JM; van der Straten A;
    AIDS Behav; 2021 Aug; 25(8):2430-2440. PubMed ID: 33713213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Emoji Stickers to Understand End-User Opinions of the Dapivirine Vaginal Ring for HIV Prevention.
    Katz AWK; Mansoor LE; Tsidya M; Mathebula F; Singh D; Siva S; Akello C; Chitowa TH; Garcia M; Soto-Torres L; Montgomery ET
    AIDS Behav; 2021 Dec; 25(12):3955-3966. PubMed ID: 34180041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial.
    Husnik MJ; Brown ER; Marzinke M; Livant E; Palanee-Phillips T; Hendrix CW; Matovu Kiweewa F; Nair G; Soto-Torres LE; Schwartz K; Hillier SL; Baeten JM;
    J Acquir Immune Defic Syndr; 2017 Nov; 76(3):330-337. PubMed ID: 28746164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Partner-Related Social Harms on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III Trial.
    Palanee-Phillips T; Roberts ST; Reddy K; Govender V; Naidoo L; Siva S; Gafoor Z; Pather A; Matovu F; Hlahla K; Makanani B; Nair G; Schwartz K; Torjesen K; Brown E; Soto-Torres L; Baeten J; Montgomery ET
    J Acquir Immune Defic Syndr; 2018 Dec; 79(5):580-589. PubMed ID: 30239426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.